UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

                             _______________________

                                    FORM 8-K


                                 CURRENT REPORT


                       Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934

                             _______________________


                  Date of Report
                  (Date of earliest
                  event reported):       June 11, 1998


                         National Research Corporation                     
             (Exact name of registrant as specified in its charter)


      Wisconsin                     0-29466                    47-0634000    
   (State or other              (Commission File             (IRS Employer   
   jurisdiction of                   Number)              Identification No.)
   incorporation)


                    1033 "O" Street, Lincoln, Nebraska  68508         
          (Address of principal executive offices, including zip code)


                                 (402) 475-2525          
                         (Registrant's telephone number)


   

   Item 2.  Acquisition or Disposition of Assets.

          On June 11, 1998 (but effective for all business and accounting
   purposes as of the close of business on May 31, 1998), National Research
   Corporation (the "Company") acquired substantially all of the assets of
   Healthcare Research Systems, Ltd., an Ohio limited liability company
   ("HRS"), pursuant to an Asset Purchase Agreement, dated as of June 11,
   1998, by and among the Company, HRS and the members of HRS (the "Purchase
   Agreement").  The Company's acquisition of the assets of HRS as well as
   the consummation of the transactions related thereto is referred to herein
   as the "Acquisition."  To date, the Company has paid a total cash
   consideration of $5,417,515 in the Acquisition and has paid or accrued
   approximately $126,000 of direct acquisition costs.

          Pursuant to the Purchase Agreement, except for certain excluded
   assets (including cash, tax credits and records, obligations of affiliates
   of HRS and organization and capitalization records), the Company acquired
   all of the business, rights, claims and assets of HRS including, but not
   limited to, HRS' (a) leased real property, (b) personal property, (c)
   personal property leases, (d) trademarks and other intellectual property,
   (e) contracts and purchase and sales orders, (f) computer software and
   hardware, (g) sales and promotional literature, (h) records, files,
   customer lists and other data, (i) inventories, (j) accounts receivable,
   (k) licenses and permits, (l) interests in the name "Healthcare Research
   Systems" and the letters "HRS" and derivatives therefrom and names similar
   thereto and (m) general intangibles.  The Company did not assume any
   liabilities of HRS in the Acquisition except for certain specified
   liabilities including (a) certain contractual obligations, (b) liabilities
   under certain permits and licenses, (c) specified accounts payable, (d)
   product or service warranty, rework or return liabilities and (e) a
   portion of certain audit fees.

          The Company acquired the assets of HRS for (i) the assumption of
   the certain specified liabilities; (ii) $5,417,515 in cash at the closing
   of the Acquisition; (iii) the post-closing determination of the dollar
   amount by which the net current assets of HRS as of May 31, 1998 exceeded
   the liabilities of HRS assumed by the Company in the Acquisition, $350,000
   of which was paid to HRS at the closing of the Acquisition as an estimate
   of such amount; (iv) an additional payment of up to $1,500,000 payable in
   April 1999 if 1998 revenues recognized for certain accounts of HRS ("HRS
   Revenues") exceed a specified level; and (v) an additional payment of
   $1,500,000 payable in June 1999, subject to a potential downward
   adjustment if HRS Revenues do not exceed a specified level.  However, in
   the event the Company does not collect all May 31, 1998 accounts
   receivable and costs in excess of billings of HRS by December 31, 1998,
   the Company will reduce the additional payment specified in clause (iv)
   above by the dollar amount of such uncollected items.  The purchase price
   paid by the Company for the assets of HRS was determined on the basis of
   arm's length negotiations between the parties.  The Company funded the
   Acquisition and paid costs associated with the Acquisition through
   available cash.

          In connection with the Acquisition, the Company entered into an
   employment agreement (which contains noncompetition and confidentiality
   provisions) with the founder and former president of HRS and
   noncompetition and confidentiality agreements with certain former
   employees of HRS who became employees of the Company following the
   consummation of the Acquisition. 

          The Purchase Agreement is filed as an exhibit to this Current
   Report on Form 8-K and is incorporated herein by reference.  The brief
   summary of the material provisions of the Purchase Agreement set forth
   above is qualified in its entirety by reference to the Purchase Agreement
   filed as an exhibit hereto.

          Similar to the Company, HRS was engaged in the design, production,
   marketing, distribution and sale of survey-based performance measurement
   analysis and tracking services and products for the healthcare industry. 
   The Company intends to continue that business. 

   Item 7.  Financial Statements and Exhibits.

          (a)   Financial Statements of Business Acquired.

          The required financial statements for HRS are not filed with this
   Current Report on Form 8-K, but will be filed as soon as practicable and
   in no event later than August 25, 1998.

          (b)   Pro Forma Financial Information.

          The required pro forma financial information is not filed with this
   Current Report on Form 8-K, but will be filed as soon as practicable and
   in no event later than August 25, 1998.

          (c)   Exhibits.

          The exhibits listed in the accompanying Exhibit Index are filed as
   part of this Current Report on Form 8-K.

   
                                   SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of
   1934, the registrant has duly caused this report to be signed on its
   behalf by the undersigned hereunto duly authorized.

                                   NATIONAL RESEARCH CORPORATION


   Date: June 22, 1998             By: /s/ Patrick E. Beans
                                       Patrick E. Beans
                                       Vice President, Treasurer, Secretary
                                       and Chief Financial Officer

   

                          NATIONAL RESEARCH CORPORATION

                            EXHIBIT INDEX TO FORM 8-K
                           Report Dated June 11, 1998


   Exhibit
     No.         Description

   (2)           Asset Purchase Agreement, dated as of June 11, 1998, by
                 and among National Research Corporation, Healthcare
                 Research Systems, Ltd., and the members of Healthcare
                 Research Systems, Ltd.*


   __________
   *   The schedules and exhibits to this document are not being filed
       herewith.  The registrant agrees to furnish supplementally a copy
       of any such schedule or exhibit to the Securities and Exchange
       Commission upon request.